Association of differential gene expression with imatinib mesylate and omacetaxine mepesuccinate toxicity in lymphoblastoid cell lines
Open Access
- 23 August 2012
- journal article
- research article
- Published by Springer Nature in BMC Medical Genomics
- Vol. 5 (1) , 37
Abstract
Imatinib mesylate is currently the drug of choice to treat chronic myeloid leukemia. However, patient resistance and cytotoxicity make secondary lines of treatment, such as omacetaxine mepesuccinate, a necessity. Given that drug cytotoxicity represents a major problem during treatment, it is essential to understand the biological pathways affected to better predict poor drug response and prioritize a treatment regime.Keywords
This publication has 50 references indexed in Scilit:
- Dynamics of chronic myeloid leukemia response to long-term targeted therapy reveal treatment effects on leukemic stem cellsBlood, 2011
- Genomewide Expression Profiling of Cryptolepine-Induced Toxicity inSaccharomyces cerevisiaeAntimicrobial Agents and Chemotherapy, 2008
- Discovery of expression QTLs using large-scale transcriptional profiling in human lymphocytesNature Genetics, 2007
- The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene listsGenome Biology, 2007
- Gleevec Increases Levels of the Amyloid Precursor Protein Intracellular Domain and of the Amyloid-β–degrading Enzyme NeprilysinMolecular Biology of the Cell, 2007
- Gene expression profiling reveals different pathways related to Abl and other genes that cooperate with c-Myc in a model of plasma cell neoplasiaBMC Genomics, 2007
- DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene listsNucleic Acids Research, 2007
- Microarray validation: factors influencing correlation between oligonucleotide microarrays and real-time PCRBiological Procedures Online, 2006
- Bim and Bad mediate imatinib-induced killing of Bcr/Abl + leukemic cells, and resistance due to their loss is overcome by a BH3 mimeticProceedings of the National Academy of Sciences, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001